
南美洲和中美洲智能药丸市场预测至 2028 年 – COVID-19 影响和区域分析 – 按应用(胶囊内窥镜检查、药物输送和患者监测)、疾病适应症(胃肠道疾病、神经系统疾病、癌症、遗传性疾病)和其他疾病适应症)和最终用户(医院和诊所、研究机构和家庭医疗保健)
No. of Pages: 108 | Report Code: BMIRE00025534 | Category: Life Sciences
No. of Pages: 108 | Report Code: BMIRE00025534 | Category: Life Sciences
电子元件的小型化对于智能药丸设计至关重要。随着云计算和无线通信程序融入医疗保健系统,使用智能药丸来监测生命体征和用药依从性的情况可能会增加。未来,智能药丸预计将成为远程患者监护和远程医疗不可或缺的组成部分。随着无创即时检测需求的增加,智能药丸将成为主流设备。电池技术(提供更长的使用寿命)和板载内存的发展使其可用于体内的长期传感。这种多维性能是传统口服药物形式无法实现的。智能药丸已经改变了胃肠道疾病的诊断,并有望取代内窥镜检查等传统诊断技术。智能药丸还用于输送胰岛素,根据患者当前的血糖水平定制并按需输送。预计该领域研发活动的增加将推动智能药丸市场的发展。 2019 年,麻省理工学院 (MIT) 的研究人员开发了一种名为 SOMA 的智能药丸——一种自定向毫米级涂抹器——包含与传统套件中使用的相同类型的胰岛素。该药丸由一个胶囊和一根由冻干胰岛素制成的小针组成。
凭借新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动智能药丸市场的发展。南部和南部预计中美洲智能药丸市场在预测期内将以良好的复合年增长率增长。
南部&中美洲智能药丸市场根据应用、疾病适应症和最终用户进行细分。根据应用,市场分为胶囊内窥镜、药物输送和患者监护。胶囊内窥镜细分为小肠视频胶囊内窥镜、结肠胶囊内窥镜、可控胶囊内窥镜、可储存胶囊内窥镜和其他胶囊内窥镜。根据疾病适应症,市场分为胃肠道疾病、神经系统疾病、癌症、遗传性疾病和其他疾病适应症。根据最终用户,市场分为医院和诊所、研究机构和家庭医疗保健。按国家、南部和地区划分中美洲智能药丸市场分为巴西、阿根廷和南美其他地区。中美洲。
南美洲和南美洲。中美洲智能药丸市场 – 提及的公司
美敦力;宾得医疗;奥林巴斯公司;和大冢控股有限公司是南部和南部地区的领先公司之一。中美洲智能药丸市场。
Strategic insights for South & Central America Smart Pills involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 170.82 Million |
Market Size by 2028 | US$ 322.58 Million |
Global CAGR (2021 - 2028) | 9.5% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 应用
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South & Central America Smart Pills refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South & Central America Smart Pills Market is valued at US$ 170.82 Million in 2021, it is projected to reach US$ 322.58 Million by 2028.
As per our report South & Central America Smart Pills Market, the market size is valued at US$ 170.82 Million in 2021, projecting it to reach US$ 322.58 Million by 2028. This translates to a CAGR of approximately 9.5% during the forecast period.
The South & Central America Smart Pills Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Smart Pills Market report:
The South & Central America Smart Pills Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Smart Pills Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Smart Pills Market value chain can benefit from the information contained in a comprehensive market report.